ARI 
 JRI 
 ISERB 
blogger delicious digg diigo facebook googleplus linkedin netlog reddit twitter
Skip Navigation Links



Volume 19, Issue 1, Number 74 / January-March
(Short Communication, pages 49-55)


Yeast and Fertility: Effects of In Vitro Activity of Candida spp. on Sperm Quality


PMID: 29850447 (PubMed) - PMCID: PMC5960052


Grupo Reproducción, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad de Antioquia, Medellín, Antioquia, Colombia

Grupo Reproducción, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad de Antioquia, Medellín, Antioquia, Colombia

 Corresponding Author
Grupo Reproducción, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad de Antioquia, Medellín, Antioquia, Colombia

Received: 6/28/2017 Accepted: 10/3/2017

Related Articles
in Google Scholar in PubMed

 

Other Format
pdfPDF Full Text (En) pubreader PubReader pdfePUB Full Text (En) pdfPDF Abstract (En) pdfPDF Abstract (Fa) pdf BibTeX pdfRefMan pdfEndNote xmlPMC XML online readerPMC Reader

 


Abstract

Background: Candida spp. causes semen candidiasis, the most important sexually transmitted fungal infection; this microorganism affects male fertility potential and could alter oocyte fertilization. The in vitro effects of the yeasts Candida albicans and Candida glabrata and their soluble factors of fungal metabolism on semen quality were studied. 
Methods: Candida strains (2, 0.5 and 0.05 McF) and their soluble factors were incubated for 3 hr with selected spermatozoa. Conventional (Viability and motility) and functional parameters (Mitochondrial membrane potential, membrane integrity, detection of reactive oxygen species and DNA fragmentation) were quantified in 35 semen samples. In addition, human spermatozoa were incubated under capacitating conditions with Candida spp. and soluble factors. Finally, spermatozoa were incubated with mannose before incubation with either yeast to block sperm and yeast interaction. Data was analyzed using Friedman test, and p<0.05 was considered significant.
Results: The conventional sperm parameters were statistically affected by the two yeast strains after 3 hr and their effect was maintained until the 24 hr incubation. However, the functional parameters were altered, this change was not statistically significant. Pretreatment of spermatozoa with mannose decreased the effect of Candida spp. 
Conclusion: The presence of C. albicans or C. glabrata affects seminal parameters. The effect is related to incubation time and yeast concentration, it can be supposed that the yeast sperm interaction is mediated through the mannose sperm receptor.



Keywords: Candida albicans, Candida glabrata, Male infertility, Semen, Spermatozoa


To cite this article:


Full Text

Introduction
Male fertility potential is related to the quality of the sperm present in the ejaculate. During ejaculation, semen is produced from a concentrated suspension of spermatozoa (~10%) stored in the paired epididymides, vas deferens and fluid secretions from the accessory sex organs (1). Seminal fluid can hold and transport bacteria, fungi, parasites and viruses that provide adequate conditions for microorganism survival in seminal plasma (2-5).
The male urogenital tract is colonized by these etiological agents that sometimes interference with sperm functions and cause infertility (6). The effect of viral and bacterial infections is commonly evaluated, while those caused by fungi are undervalued (7, 8). Candida spp., Aspergillus spp., Cryptococcus spp., and Coccidioides spp. account for more than 90% of the systemic mycoses reported and are caused by fungi. In the male reproductive tract, fungus causes urethritis, balanopos-thitis, ulcers, pseudotumor, orchitis and prostatitis (7, 9, 10). Candidiasis is considered as the only sexually transmitted yeast infection; it is caused by Candida spp., Candida albicans and C. glabrata as the most prevalent species (11), and this infection is much more common in women than in men (2, 11). However, men can act as infection reservoir. Contact of C. albicans, or the soluble factor of fungal metabolism with seminal plasma alters sperm quality, either in the male reproductive tract (before ejaculation) or in the female reproductive tract (after ejaculation or sperm capacitation) (8, 12, 13).
Some in vitro studies report decreased motility and sperm viability, increased sperm DNA fragmentation, and alteration of the mitochondrial membrane affecting the potential of male fertility and nonspecific agglutinations (8, 12, 13). Conversely, the effects of C. glabrata on sperm cells are still unknown.
Burrello et al. (8, 14) reported that failure in the assisted reproductive program could occur in patients with C. albicans infections due to the increase of DNA fragmentation and apoptosis, but without affecting conventional sperm parameters. Even gradient methodologies commonly used in in semen processing reproductive programs cannot remove C. albicans contamination (8, 14). In addition, Tian et al. (13) demonstrated that C. albicans infection affects sperm motility and damages the ultrastructure of sperm cells.
Based on the previous demonstrations, within the diagnosis of yeast infection, it is mandatory to: i) determine the effect of C. albicans and C. glabrata on functional sperm parameters; ii) determine the possible receptor involved in the sperm and Candida spp. interaction, since this is important for medical and reproductive programs. These results will demonstrate further knowledge about Candida spp. infections and appropriate treatments to prevent possible negative results in the procedure of assisted reproduction.
The aim of this study was to evaluate the in vitro effects of C. albicans, C. glabrata and their soluble factors of fungal metabolism on sperm quality.

Methods
Yeast: C. albicans and C. glabrata strains (kindly donated by the Institución Universitaria Colegio Mayor de Antioquia. Medellín, Colombia) were conserved on Sabouraud agar (Thermo Fisher Scientific, Waltham, MA, USA) at 4°C. Two days before use, each strain was reactivated in brain heart infusion (BHI, Thermo Fisher Scientific, Eugene, OR, USA) at 37°C.
Sperm samples: Thirty-five semen samples were donated by apparently healthy volunteers, aged between 18 and 32 years, collected by masturbation after a sexual abstinence period of 3 to 5 days and analyzed during the first hour after sample collection at the Reproduction Group, Medical School of the University of Antioquia. The conventional seminal parameters were determined in each semen sample following the guidelines established in the semen processing manual of the World Health Organization (WHO), and sperm concentrations were determined using a Makler chamber (Sefi-Medical Instruments). All the samples had seminal parameters equal to or above the lower reference limits established by WHO in 2010. Exclusion criteria for study participation were any history of urogenital surgery and leuko-cytospermia as well as self-reported illnesses or use of medication in the three months immediately preceding the study.
Sperm selection: Motile sperm were selected using the gradient technique (PureSperm® Nidacon, Gothen-burg, Sweden). Briefly, in a 15 ml conical tube, 500 μl of the denser phase (PureSperm® 80), 500 μl of the less dense phase (PureSperm® 40) and 1000 μl of semen over both phases were added, and the mixture was centrifuged 20 min at 300 g. Finally, the supernatant was removed and the motile sperm was re-suspended in 1 ml Ham’s-F10 medium (Gibco Life Technologies, Breda, Netherlands).
Yeast inoculum and soluble factor of fungal metabolism: 2, 0.5 (1-5x106 yeast/ml) and 0.05 Mc Farland (McF) yeast inoculums in phosphate-buffered saline (PBS, Gibco Life Technologies, Grand Island, NY, USA) were incubated with three different relation between motile sperm and Candida spp. Candida and sperm ratios were 1 to 1 (0.5 McF), 1 to 10 (0.05 McF) and 4 to 1 (2 McF). The 0.05 McF inoculum was prepared from a 1:10 dilution of 0.5 McF. 
Soluble factors of fungal metabolism (SFFM) of C. albicans and C. glabrata were obtained after a 0.5 McF PBS (Gibco Life Technologies) incubation for 1 hr at 37°C. Next, the medium was centrifuged for 5 min at 2300 g and subsequently filtered through a 0.2 µm membrane (Advantec Industries, Yinzhou District, Ningbo, China). The filtrate was aliquoted and stored at -20°C until used.
Evaluation of the effect of C. albicans, C. glabrata and SFFM on conventional sperm parameters: Three concentrations (2, 0.5 and 0.05 McF) of each yeast strain and 0,5 McF SFFM were incubated with five million selected sperm and the effect of incubation over conventional sperm parameters was determined after 0, 1, 2 and 3 hr of incubation at 37°C following intervals previously described (8, 13). The results are expressed as the percentage of change in viability and progressive sperm motility relative to the control (Spermatozoa incubated in PBS).
Evaluation of the effect of C. albicans, C. glabrata and SFFM on capacitated spermatozoa: Five million selected sperm were incubated in four different conditions: i) Capacitation medium (MC, Ham's F10-Gibco Life Technologies- with 35 mg/ml bovine serum albumin (Sigma-Aldrich, St. Louis, MO, USA)), ii) Non-capacitation medium (Ham's F10-NC), iii) Capacitation medium with 0.5 McF SFFM (MC-FS), and iv) Capacitation medium with Candida spp., 0.05 McF (MC-0.05 McF). Finally, the progressive motility in the initial time (0 hr), and 6, 18 and 24 hr post capacitation was evaluated.
Evaluation of the effect of the SFFM of C. albicans and C. glabrata on the functional parameters: Fifteen million previously selected sperm were incubated with 0.5 McF SFFM of Candida spp. in a ratio of 1:1 v/v, for 3 hr at 37°C. The control was 15 million spermatozoa incubated with PBS. The following functional tests were evaluated, analyzing a total of 10000 events for each sample according to previously established protocols (15-22).
Mitochondrial membrane potential (∆Ψm): One million sperm were incubated with 3,3′-dihexyl-oxacarbocyanine iodide DIOC6 (final concentration 10 nM, Molecular Probes Inc., Thermo Fisher Scientific) and propidium iodide (PI, final concentration 12 µM, Molecular Probes Inc., Thermo Fisher Scientific) in the dark (30 min, 25°C). The samples were washed in PBS, centrifuged at 180 g for 5 min, and the pellets resuspended in PBS and subjected to flow cytometry. Data were acquired as the percentage of living spermatozoa showing high (∆Ψm high) or low (∆Ψm low) green fluorescence, and dead spermatozoa-red fluorescence (19, 21).
Evaluation of plasma membrane integrity: One million sperm were incubated in Sybr-14 and PI (Final concentrations of 1 μM and 12 µM, respectively, The LIVE/DEAD® Sperm Viability Kit, Molecular Probes Inc., Thermo Fisher Scientific) in the dark (30 min, 25°C), washed once and re-suspended in PBS prior to flow cytometry analysis. The data are expressed as the percentage of viable spermatozoa (19, 21).
Lipid peroxidation assay: One million sperm were incubated in the dark (30 min, 25°C) with BODIPY C11 (Final concentration 6.6 µM, Molecular Probes Inc., Thermo Fisher Scientific), washed and resuspended in PBS before flow cytometry analysis. The results are expressed as the percentage of spermatozoa exhibiting a green fluorescence response (15).
Production of intracellular reactive oxygen species: One million sperm were incubated with PI (final concentration 12 µM) and 2’,7’-dichlorodihydro-fluorescein diacetate (DCFH-DA, Sigma-Aldrich, St Louis, MO, USA, final concentration 1 μM) in the dark for 5 min, at 25ºC, washed three times with PBS (180 g, 5 min) and the pellets re-suspended in PBS before being analyzed by flow cytometry. The results are expressed as the percentage of spermatozoa exhibiting the green fluorescence response (23-25).
Sperm chromatin structure assay: Five million sperm were suspended in 200 µl of TNE buffer (Tris-HCl, NaCl and EDTA, pH=7.4). Before reading on the cytometer, 200 ml of acid detergent solution (HCl, NaCl, Triton X-100, water, pH=1.2) was added and 30 s after, the sperm were stained with 600 µl of acridine orange (Sigma-Aldrich) staining solution (6 µg/ml). The ratio of single stranded DNA (red) to single plus double stranded DNA (green) media fluorescence intensity (MFI) is expressed as the DNA fragmentation index (DFI) (19, 21).
Detection of membrane phosphatidylserine exposure: An aliquot of 2x106 spermatozoa was re-suspended in binding buffer, labeled with Annexin-FITC plus PI, incubated for 15 min in the dark, followed by the addition of binding buffer (10x: 0.1 M Hepes pH=7.4, 1.4 M NaCl; 25 mm CaCl2) and then immediately transferred to a flow cytometer and analyzed according to the manufacturer’s instructions (eBioscience Apoptosis Detection Kit FITC; BD, Thermo Fisher Scientific). The results are expressed as percentage of cells for each population of interest, phosphatidylserine exposure and PI positive (23).
Blockage of the mannose receptor: Sperm cells were incubated with mannose (Sigma-Aldrich, St. Louis, MO, USA, 100 μM) for 1 hr and subsequently, the sperm cells were incubated with each yeast (0.5 McF). The results are expressed as the percentage change in progressive sperm motility relative to the control (spermatozoa incubated in PBS) at 0 and 3 hr
Statistical analysis: The flow cytometry results of each functional parameter were processed using the FlowJo program 7.6 (TreeStar, San Carlos, CA, USA). Descriptive statistics were applied (Median and range). For the analysis of the conventional and functional parameters, a non-parametric Friedman was performed (Friedman test) considering a statistical significance of p<0.05. The assumption of normality was checked by Kolmogorov-Smirnov, Shapiro-Wilk test and D’Agostino-Pear-son using Prism 5.0 (GraphPad Software, San Diego, CA) statistical software.

Results
The effect of C. albicans, C. glabrata strains and their 0.5 McF SFFM on sperm viability is shown in figure 1. C. albicans progressively decreased sperm viability to 45% (2 McF, p<0.0001) and their SFFM to 18% (p< 0.0001) based on the control (Figure 1A), whereas C. glabrata strain achieved a maximum reduction of 42% (2 McF, p<0.0001) and their SFFM of 15% (p<0.01) with respect to the control (Figure 1B).
The effect of the strains of C. albicans, C. glabrata and their SFFM on progressive sperm motility is presented in figure 2. Immediately, when incubation began, both strains significantly decreased sperm motility, and increasing the time of incubation increased the negative effect, although this was higher when C. albicans strains (81%, p<0.0001) or their SFFM were incubated (58%, p<0.001) with respect to the control. 
During the capacitation assays, the greatest effect was demonstrated with the strain of C. albicans that reduced motility to 94% (MCA-0.05 McF, p<0.0001) while C. glabrata reduced it to 89% (MCG-0.05 McF p<0.001) (Figure 3).
The effect of 0.5 McF SFFM of the two yeast strains on the sperm functional parameters did not show statistical differences. However, C. albicans decreased early apoptotic cells by 14%, but increased late apoptosis cells by 67%, necrotic cells by 4% and DNA fragmentation index by 4.3%. As for C. glabrata, it increased early apoptosis cells by 69% and late apoptosis to 37%, but it decreased necrotic cells to 17% and DNA fragmentation index to 19% (Table 1).
Finally, the effect of C. albicans and C. glabrata on progressive motility after 1 hr of sperm pre-incubation with mannose, at 0 and 3 hr with Candida spp. is shown in figure 4. Pre-incubation of sperm with mannose reduced the effect of yeast on mobility and no statistically significant differences were observed with control. Treatment with C. albicans or C. glabrata and without mannose decreased sperm motility in both cases (0 and 3 hr) (p<0.05) compared to the control.

Discussion
In the present study, the effect of C. albicans and C. glabrata on sperm quality was evaluated. Candida spp. strains and their SFFM negatively affect the motility and sperm viability in vitro after 3 and 24 hr, and although both yeast strains significantly affect conventional parameters, C. albicans has a greater negative effect due to its virulence factors. However, with both strains, the effect is associated with yeast concentration and time of incubation. Three hours are sufficient to significantly modify the percentage of viable and progressive spermatozoa. These effects suggest that the sperm alterations caused by Candida spp. may be of greater importance during the fertility consultation. 
Men infertility is associated with a decrease in the seminal quality that is frequently affected by uropathogenic or commensal microorganisms that colonize the male and female urogenital tract. Fungal infections are mostly asymptomatic and Candida spp. is the most common cause of fungal infections. However, this yeast has a high prevalence in infections of the female reproductive tract which can affect semen quality. Few studies have evaluated the effect of Candida spp. on seminal quality (8, 12-14).
The most frequently examined yeast until 2009 due to its prevalence was C. albicans (11); among the main virulence factors expressed by this microorganism are the cellular morphology, phenotypic change, extracellular enzymatic activity (proteases and phosphatases) and adhesion factors (11). In vitro studies have shown that yeasts and their filtrates or SFFM inhibit sperm motility, and this effect has been associated with the concentration and duration of contact (8, 13). Similarly, in the study published by Tuttle et al., C. albicans significantly reduced progressive sperm motility and form to nonspecific aggregates after 2 and 4 hr, suggesting that C. albicans affects male fertility potential (12). 
Likewise, Tian et al. reported that C. albicans and its  SFFM affect sperm morphology, causing the breakdown of the acrosome, inducing the formation of vacuoles in the head of the spermatozoa, damaging the middle piece and altering the normal function of mitochondria; in addition, these authors reported the formation of nonspecific aggregates (13). Rennemeire et al. reported that SFFM from C. albicans induces loss of acrosome and sperm viability (24), and Burrello et al. reported that C. albicans sperm interaction increases the DNA fragmentation index and inhibits the fertilization process during assisted reproduction techniques (14). Burrello et al. later demonstrated alterations in sperm motility, mitochondrial membrane potential and cellular apoptosis after 3 and 24 hr of incubation with C. albicans (8). In contrast, Berktas et al. evaluated the effect of C. albicans on sperm motility at various concentrations, but found no influence of this microorganism on the seminal parameters (25).
With respect to sperm DNA damage, it is important to remark that several studies report that sperm incubation at 37oC during 3 hr is associated with DNA damage (26, 27). In our case, the treatment during 3 hr with the SFFM was not different in relation to the control. However, the higher result of SCSA test could be originated by this incubation.
On the other hand, no reports examined the effect of C. glabrata on seminal quality, although C. glabrata causes balanitis and orchitis (25). During the last three decades, an increase in the number of cases of vaginal candidiasis, candidemia and systemic fungal infections caused by this species of yeast has occurred. It has even been considered an emerging pathogen, although it appears less virulent than other Candida species, due to the absence of pseudohifas, structures that increase the adherence and penetration of the fungus into tissues and cultures. However, it is known that C. glabrata produces proteases and presents hydrophobicity on its cell surface, allowing adherence similar to that of C. albicans (28).
Regarding the functional parameters examined in the present study, no statistical differences were found. However, similar to what was reported in the literature (8), SFFM of C. albicans and C. glabrata affects some functional parameters. No reports regarding how the presence of Candida spp. affects reactive oxygen species have appeared and in this study, C. albicans decreases while C. glabrata increases them. In addition, C. glabrata decreases the lipoperoxidation of the sperm membrane.
On the other hand, during sperm travel to the female reproductive tract, sperm cells undergo the capacitation process. In the present study, Candida spp. strains, C. albicans and C. glabrata induce changes in the motility of the sperm during the capacitation process. If this same process occurs in vivo, the possibility to fertilize the oocyte decreases.
Candida spp. has mannan in the form of a glyco-protein that consists mainly of mannose residues and spermatozoa have receptors for this carbohydrate (29-32); these interactions explain these aggregations that are not present in mannose-pre-incubated samples. Therefore, in the future, a new methodology with blocked mannose receptor could be used to decrease the negative effects of Candida infection. In addition, there are several limitations in this study that should be noted. Sperm morphology and reversible effects of Candida spp. were not determined. Therefore, more studies are needed to determine the effects of in vitro or in vivo Candida spp. on motility, viability and sperm morphology.

Conclusion
The presence of C. albicans, C. glabrata and their SFFM affect seminal parameters, and this effect is related to incubation time and yeast concentration.

Conflict of Interest
The authors declare no conflict of interest.




Figures, Charts, Tables


Figure 1. Effect of Candida spp. on sperm viability. C. albicans (a), C. glabrata (b) at three concentrations (0.05, 0.5 and 2.0 McF) and their SFFM on sperm viability at 0, 1, 2 and 3 hr of incubation. The data are presented as median and a range of seven (C. albicans) or three (C. glabrata) independent experiments with duplicate determinations.
*: p&lt;0,05; **: p&lt;0,01; ***: p&lt;0,001, ****: p&lt;0,0001. SFFM: Soluble factors of fungal metabolism

Figure 1. Effect of Candida spp. on sperm viability. C. albicans (a), C. glabrata (b) at three concentrations (0.05, 0.5 and 2.0 McF) and their SFFM on sperm viability at 0, 1, 2 and 3 hr of incubation. The data are presented as median and a range of seven (C. albicans) or three (C. glabrata) independent experiments with duplicate determinations.

*: p<0,05; **: p<0,01; ***: p<0,001, ****: p<0,0001. SFFM: Soluble factors of fungal metabolism




Figure 2. Effect of Candida spp. on sperm motility. C. albicans (a) and C. glabrata (b) at three different concentrations (0.05, 0.5 and 2.0 McF) and their SFFM on the motility of progressive sperm at 0, 1, 2 and 3 hr of incubation. The data are presented as median and a range of seven (C. albicans) or three (C. glabrata) independent experiments with duplicate determinations.
*: p&lt;0,05; **: p&lt;0,01; ***: p&lt; 0,001, ****: p&lt;0,0001. SFFM: Soluble factors of fungal metabolism

Figure 2. Effect of Candida spp. on sperm motility. C. albicans (a) and C. glabrata (b) at three different concentrations (0.05, 0.5 and 2.0 McF) and their SFFM on the motility of progressive sperm at 0, 1, 2 and 3 hr of incubation. The data are presented as median and a range of seven (C. albicans) or three (C. glabrata) independent experiments with duplicate determinations.

*: p<0,05; **: p<0,01; ***: p< 0,001, ****: p<0,0001. SFFM: Soluble factors of fungal metabolism




Figure 3. Effect of Candida spp. on sperm capacitation process. C. albicans (a) and C. glabrata (b) on progressive motility during sperm capacitation process. MC: Capacitating medium, MC-FS: Capacitating medium and 100 &micro;l SFFM, MC-0.05 McF: Capacitating medium and Candida =0.05 McF, NC: Non-capacitating medium. Data are presented as median and a range of ten (C. albicans) or seven (C. glabrata) independent experiments with duplicate determinations.
*: p&lt;0,05; **: p&lt;0,01; ***: p&lt;0,001, ****: p&lt;0,0001. SFFM: Soluble factors of fungal metabolism

Figure 3. Effect of Candida spp. on sperm capacitation process. C. albicans (a) and C. glabrata (b) on progressive motility during sperm capacitation process. MC: Capacitating medium, MC-FS: Capacitating medium and 100 µl SFFM, MC-0.05 McF: Capacitating medium and Candida =0.05 McF, NC: Non-capacitating medium. Data are presented as median and a range of ten (C. albicans) or seven (C. glabrata) independent experiments with duplicate determinations.

*: p<0,05; **: p<0,01; ***: p<0,001, ****: p<0,0001. SFFM: Soluble factors of fungal metabolism




Figure 4. Mannose receptor mediates sperm cell interaction with Candida spp. Effect of C. albicans and C. glabrata on progressive motility after sperm pre-incubation with mannose for 0 or 3 hr. Data are presented as median and a range of three independent experiments with duplicate determinations. *: p&lt;0,05

Figure 4. Mannose receptor mediates sperm cell interaction with Candida spp. Effect of C. albicans and C. glabrata on progressive motility after sperm pre-incubation with mannose for 0 or 3 hr. Data are presented as median and a range of three independent experiments with duplicate determinations. *: p<0,05




Table 1. Effect of the 0.5 McF soluble factors of Candida spp. on the functional parameters
a: vs control p&gt;0.05 (No statistical significant def.) Mitochondrial membrane potential (∆&Psi;m)

Table 1. Effect of the 0.5 McF soluble factors of Candida spp. on the functional parameters

a: vs control p>0.05 (No statistical significant def.) Mitochondrial membrane potential (∆Ψm)



References
  1. World Health Organization. World Health Organiza-tion laboratory manual for the examination and processing of human semen. 5th ed. Geneva, Swit-zerland: World Health Organization. 2010. p. 286.
  2. Alsterholm M, Flytström I, Leifsdottir R, Faerge-mann J, Bergbrant IM. Frequency of bacteria, Candida and malassezia species in balanoposthitis. Acta Derm Venereol. 2008;88(4):331-6.   [PubMed]
  3. Puerta Suárez J, Villegas Castaño A, Serna Quintana GJ, Martínez A, Romero Palacio J, Giraldo M, et al. [Spermoculture: Bacterial growth in ejaculation and its relationship with the seminal parameters]. Rev Chil Obstet Ginecol. 2015;80(1):33-40. Spanish.
  4. Cardona Maya WD, Du Plessis SS, Velilla PA. Semen as virus reservoir? J Assist Reprod Genet. 2016;33(9):1255-6.   [PubMed]
  5. Puerta Suárez J, Cardona Maya WD. [Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Ureaplasma urealyticum in semen samples: effects on sperm quality]. Urología Colomb. 2016;25(3):219-24. Spanish.
  6. Ahmad G, du Plessis SS, Agarwal A. Sexually Transmitted Infections and Impact on Male Fertility. In: Gunasekaran K, Pandiyan N, editors. Male Infertility: A Clinical Approach. New Delhi: Springer India; 2017. p. 167-83.
  7. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13.   [PubMed]
  8. Burrello N, Salmeri M, Perdichizzi A, Bellanca S, Pettinato G, D'Agata R, et al. Candida albicans experimental infection: effects on human sperm motility, mitochondrial membrane potential and apoptosis. Reprod Biomed Online. 2009;18(4):496-501.   [PubMed]
  9. Wise GJ, Talluri GS, Marella VK. Fungal infections of the genitourinary system: manifestations, diagnosis, and treatment. Urol Clin North Am. 1999;26(4):701-18, vii.   [PubMed]
  10. Aridogan IA, Izol V, Ilkit M. Superficial fungal infections of the male genitalia: a review. Crit Rev Microbiol. 2011;37(3):237-44.   [PubMed]
  11. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23 (2):253-73.   [PubMed]
  12. Tuttle JP Jr, Bannister ER, Derrick FC. Interference of human spermatozoal motility and sperm-atozoal agglutina-tion by Candida albicans. J Urol. 1977;118(5):797-9.   [PubMed]
  13. Tian YH, Xiong JW, Hu L, Huang DH, Xiong CL. Candida albicans and filtrates interfere with human spermatozo-al motility and alter the ultrastructure of spermatozoa: an in vitro study. Int J Androl. 2007;30(5):421-9.   [PubMed]
  14. Burrello N, Calogero AE, Perdichizzi A, Salmeri M, D'Agata R, Vicari E. Inhibition of oocyte fertilization by as-sisted reproductive techniques and increased sperm DNA fragmentation in the presence of Candida albicans: a case report. Reprod Biomed Online. 2004;8(5):569-73.   [PubMed]
  15. Aitken RJ. Sperm function tests and fertility. Int J Androl. 2006;29(1):69-75.   [PubMed]
  16. Gil-Villa AM, Cardona-Maya W, Agarwal A, Shar-ma R, Cadavid A. Role of male factor in early recurrent embryo loss: do antioxidants have any effect? Fertil Steril. 2009;92(2):565-71.   [PubMed]
  17. Gil-Villa AM, Cardona-Maya W, Agarwal A, Shar-ma R, Cadavid A. Assessment of sperm factors possibly in-volved in early recurrent pregnancy loss. Fertil Steril. 2010;94(4):1465-72.   [PubMed]
  18. Rodríguez E, Gil-Villa AM, Aguirre-Acevedo DC, Cardona-Maya W, Cadavid AP. [Evaluation of atypical semen parameters in individuals whose couples had a history of early recurrent embryo death: in search for a reference value]. Biomedica. 2011;31(1):100-7. Spanish.   [PubMed]
  19. Mayorga-Torres BJ, Cardona-Maya W, Cadavid Á, Camargo M. [Evaluation of sperm functional parameters in normozoospermic infertile individuals]. Actas Urol Esp. 2013;37(4):221-7. Spanish.   [PubMed]
  20. Mayorga-Torres BJ, Camargo M, Agarwal A, du Plessis SS, Cadavid ÁP, Cardona Maya WD. Influence of ejacula-tion frequency on seminal parameters. Reprod Biol Endocrinol. 2015;13:47.   [PubMed]
  21. Lalinde-Acevedo PC, Mayorga-Torres BJM, Agar-wal A, du Plessis SS, Ahmad G, Cadavid ÁP, et al. Physically Active Men Show Better Semen Parameters than Their Sedentary Counterparts. Int J Fertil Steril. 2017;11(3):156-65.   [PubMed]
  22. Mayorga-Torres BJM, Camargo M, Cadavid ÁP, du Plessis SS, Cardona Maya WD. Are oxidative stress markers associated with unexplained male infertility? Andrologia. 2017;49(5).   [PubMed]
  23. Glander HJ, Schaller J. Binding of annexin V to plasma membranes of human spermatozoa: a rapid assay for detection of membrane changes after cryo-storage. Mol Hum Reprod. 1999;5(2):109-15.   [PubMed]
  24. Rennemeier C, Frambach T, Hennicke F, Dietl J, Staib P. Microbial quorum-sensing molecules induce acrosome loss and cell death in human spermatozoa. Infect Immun. 2009;77(11):4990-7.   [PubMed]
  25. Berktas M, Aydin S, Yilmaz Y, Cecen K, Bozkurt H. Sperm motility changes after coincubation with various uropathogenic microorganisms: an in vitro experimental study. Int Urol Nephrol. 2008;40(2):383-9.   [PubMed]
  26. Matsuura R, Takeuchi T, Yoshida A. Preparation and incubation conditions affect the DNA integrity of ejaculated human spermatozoa. Asian J Androl. 2010;12(5):753-9.   [PubMed]
  27. Nabi A, Khalili MA, Halvaei I, Roodbari F. Prolonged incubation of processed human spermatozoa will increase DNA fragmentation. Andrologia. 2014;46(4):374-9.   [PubMed]
  28. del Valle GM. Candida glabrata: un patógeno emergente. Biociencias. 2016;10(1):89-102.
  29. Cardona-Maya WD, Cadavid AP. [Evaluation of the role of the monosaccharides, mannose and N-acetylglucosamine in the induction of the acrosome reaction in human spermatozoa]. Actas Urol Esp. 2005;29(7):676-84. Spanish.   [PubMed]
  30. Cardona-Maya W, Velilla P, Montoya CJ, Cadavid A, Rugeles MT. Presence of HIV-1 DNA in spermatozoa from HIV-positive patients: changes in the semen parameters. Curr HIV Res. 2009;7(4): 418-24.   [PubMed]
  31. Cardona-Maya W, Velilla PA, Montoya CJ, Cada-vid Á, Rugeles MT. In vitro human immunodeficiency virus and sperm cell interaction mediated by the mannose receptor. J Reprod Immunol. 2011;92 (1-2):1-7.   [PubMed]
  32. Cardona-Maya W, López-Herrera A, Velilla-Her-nández P, Rugeles MT, Cadavid AP. The role of mannose receptor on HIV-1 entry into human spermatozoa. Am J Reprod Immunol. 2006;55(4):241-5.   [PubMed]



Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and copyrighted by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2016 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.